We are pleased to announce the promotion of Scott Gilbert to Partner. Scott is a leader in our San Francisco office and has been a major contributor to multiple practices, including New Product Strategy, Established Product & Franchise Strategy, and Pricing, Reimbursement & Market Access. Since joining the firm as an Associate Consultant, Scott has become a trusted advisor to life sciences companies across a wide range of specialty and primary care therapeutic areas in both domestic and international markets.
“Scott has been a driving force behind the firm’s continued success and growth. Over the last decade, he has exemplified the firm’s commitment to providing exceptional service to our clients.” said Eric Auger, Partner & Partnership Chair. “We are excited to share in this career milestone with him.”
Scott has extensive expertise in advanced quantitative analyses, including quantitative primary research, medical claims analysis, forecasting and scenario modeling. He has served prominent clients across therapeutic areas including oncology, hematology, nephrology, asthma, vaccine, osteoporosis, cardiovascular, neuroscience, HIV, hospital anti-infectives, transplantation, and dermatology. His recent engagements have included new product launches, portfolio prioritization, growth strategies, physician segmentation, pricing / managed markets strategy development, and product forecasting. Scott joined Putnam after graduating from Dartmouth with a B.A. in Biology with a focus on Economics.